Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab

Journal of the European Academy of Dermatology and Venereology

Volumn 32, Issue 7, 2018, Pages e256-e257

  Page, B ^a   Borradori, L ^a   Beltraminelli, H ^a   Yawalkar, N ^a   Hunger, R E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; IPILIMUMAB; LEVOCETIRIZINE; NIVOLUMAB; PREDNISOLONE; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; BRAIN METASTASIS; CASE REPORT; CLINICAL ARTICLE; EOSINOPHIL; ERYTHEMA; HUMAN; LETTER; LEUKOCYTE COUNT; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; MELANOMA; MICROSCOPY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; PRIORITY JOURNAL; PATHOLOGY; SECONDARY; SKIN TUMOR;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; HUMANS; IPILIMUMAB; MALE; MELANOMA; MIDDLE AGED; NIVOLUMAB; SKIN NEOPLASMS;

EID: 85019730110     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.14282     Document Type: Letter

References (5)

1. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP) – a clinical reaction pattern. J Cutan Pathol 2001; 28: 113–119.
2. Kostopoulos TC, Krishna SM, Brinster NK, Ortega-Loayza AG. Acute generalized exanthematous pustulosis: atypical presentations and outcomes. J Eur Acad Dermatol Venereol 2015; 29: 209–214.
3. Lee SK, Lee DY, Kim DJ, Kim MS, Lee UH, Hahm JH. Acute generalized exanthematous pustulosis induced by celecoxib. J Cutan Pathol 2016; 43: 80–81.
4. Postow MA, Chesney J, Pavlick AC et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med 2015; 372: 2006–2017.
5. Nayar N, Briscoe K, Fernandez Penas P. Toxic epidermal necrolysis-like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma. J Immunother 2016; 39: 149–152.